DSM-5, psychiatric epidemiology and the false positives problem

Epidemiology and Psychiatric Sciences

Volumn 24, Issue 3, 2015, Pages 188-196

  Wakefield, J C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attention deficit hyperactivity disorder; bereavement exclusion; depression; diagnosis and classification; DSM 5; harmful dysfunction; intermittent explosive disorder; major depression; mental disorder; psychiatric diagnosis; substance use disorder

Indexed keywords

ADDICTION; ANGER; ATTENTION DEFICIT DISORDER; BEREAVEMENT; COMORBIDITY; DEPENDENT PERSONALITY DISORDER; DSM-5; DSM-III; DSM-IV; FALSE POSITIVE RESULT; HUMAN; INTERMITTENT EXPLOSIVE DISORDER; MAJOR DEPRESSION; PSYCHIATRIC DIAGNOSIS; REVIEW; SEXUAL DYSFUNCTION; SUBSTANCE USE; VERBAL HOSTILITY;

EID: 84929266607     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796015000116     Document Type: Review

References (81)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn: DSM-IV. American Psychiatric Association: Washington, DC.
2. American Psychiatric Association (2013). Diagnostic and Statistical Manual of mental Disorders, 5th edn: DSM-5. American Psychiatric Association: Arlington, VA.
3. Center for Disease Control and Prevention. (2013). Key findings: trends in the parent-report of health care provider diagnosis and medication treatment for ADHD: United States, 2003-2011. Retrieved 27 November 2013 from http://www.cdc.gov/ncbddd/adhd/features/ key-findings-adhd72013.html.
4. Clayton P, Desmarais L, Winokur G (1968). A study of normal bereavement. American Journal of Psychiatry 125, 168-178.
5. Coccaro E, Schmidt C, Samuels J, Nestadt G (2004). Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. Journal of Clinical Psychiatry 65, 820-824.
6. Coccaro EF (2011). Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Comprehensive Psychiatry 5, 119-125.
7. Coccaro EF (2012). Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. American Journal of Psychiatry 169, 577-588.
8. Coccaro EF, Kavoussi RJ, Berman ME, Lish JD (1998). Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Comprehensive Psychiatry 39, 368-376.
9. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, Flodman P, Spence MA, Schuck S, Swanson JM, Zhang YP, Moyzis RK (2002). Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proceedings of the National Academy of Science USA 99, 309-314.
10. Eisenberg DTA, Campbell B, Gray PB, Sorenson MD (2008). Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. BMC Evolutionary Biology 8. http://www.biomedcentral.com/1471-2148/8/173, 1-12.
11. Elder TE (2010). The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. Journal of Health Economics 29, 641-656.
12. Evans WN, Morrill MS, Parente ST (2010). Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children. Journal of Health Economics 29, 657-673.
13. First MB, Wakefield JC (2010). Defining 'mental disorder' in DSM-V. Psychological Medicine 40, 1779-1782.
14. Frances A (1998). Problems in defining clinical significance in epidemiological studies. Archives of General Psychiatry 55, 119.
15. Frances A (2012). DSM-5 is a guide, not a bible: simply ignore its 10 worst changes. Retrieved 25 December 2012 from http://www.huffingtonpost.com/allen-frances/ dsm-5-b-2227626.html.
16. Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW (2012). Bereavement and the diagnosis of major depressive episode in the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 73, 208-215.
17. Greenberg G (2010). Inside the battle to define mental illness. Wired 19 available at http://www.wired.com/2010/12/ff-dsmv/all/ (accessed 3 February 2015), 1-5.
18. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF (2013). DSM-5 criteria for substance use disorders: recommendations and rationale. American Journal of Psychiatry 170, 834-851.
19. Kendler KS (2013). A history of the DSM-5 scientific review committee. Psychological Medicine 43, 1793-1800.
20. Kendler KS, Appelbaum PS, Bell CC, Fulford KW, Ghaemi SN, Schaffner KF, Waterman GS, First MB, Sadler JZ (2008). Issues for DSM-V: DSM-V should include a conceptual issues work group. American Journal of Psychiatry 165, 174-175.
21. Kessler RC, Rubinow D, Holmes C, Aberson J, Zhao S (1997). The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychological Medicine 27, 1079-1089.
22. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E (2006). The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Archives of General Psychiatry 63, 669-678.
23. Maj M (2012). Bereavement-related depression in the DSM-5 and ICD-11. World Psychiatry 11, 1-2.
24. Maj M (2013). "Clinical judgment" and the DSM-5 diagnosis of major depression. World Psychiatry 12, 89-91.
25. McLaughlin KA, Green JG, Hwang I, Sampson NA, Zaslavsky AM, Kessler RC (2012). Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement. Archives of General Psychiatry 69, 1131-1139.
26. Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne B, Polanczyk G, Poulton R (2010). How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine 40, 899-909.
27. Mojtabai R (2011). Bereavement-related depressive episodes: characteristics, 3-year course, and implications for DSM-5. Archives of General Psychiatry 68, 920-928.
28. Narrow WE, Rae DS, Robins LN, Regier DA (2002). Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 survey's estimates. Archives of General Psychiatry 59, 115-123.
29. Parkes C (1964). Recent bereavement as a cause of mental illness. British Journal of Psychiatry 110, 198-204.
30. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B, Kessler RC, Norquist GS (1998). Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Archives of General Psychiatry 55, 109-115.
31. Regier DA, Narrow WE, Rae DS (2004). For DSM-V, it's the "disorder threshold," stupid. Archives of General Psychiatry 61, 1051.
32. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ (2009). The conceptual development of DSM-5. American Journal of Psychiatry 166, 645-650.
33. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ (2011). Introduction. In The Conceptual Evolution of DSM-5 (ed. DA Regier, WE Narrow, EA Kuhl and DJ Kupfer), pp. xxi-xxix. American Psychiatric Publishing: Arlington, VA.
34. Rohde P, Lewinsohn PM, Klein DN, Seeley JR, Gau JM (2013). Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, and adulthood. Clinical Psychological Science 1, 41-53.
35. Schatzberg AF, Scully JH, Kupfer DJ, Regier DA (2009). Setting the record straight: a response to Frances commentary on DSM-V. Psychiatric Times 26. Retrieved from http://www.psychiatrictimes.com/dsm/content/article/ 10168/1425806.
36. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, Clasen L, Evans A, Giedd J, Rapoport JL 2007. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Science USA, 104, 19649-19654.
37. Spitzer RL, Wakefield JC (1999). DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem? American Journal of Psychiatry 156, 1856-1864.
38. Sripada CS, Kessler D, AngstadtM(2014). Lag in maturation of the brain's intrinsic functional architecture in attention-deficit/hyperactivity disorder. Proceedings of the National Academy of Science USA, September 2014. DOI: 10.1073/pnas.1407787111.
39. Urbina I (2012). Addiction diagnoses may rise under guideline changes. New York Times, May 12, 2012, A11.
40. Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, Perou R, Blumberg SJ (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. Journal of the American Academy of Child and Adolescent Psychiatry 53, 34-46.
41. Wakefield JC (1992a). The concept of mental disorder: on the boundary between biological facts and social values. American Psychologist 47, 373-388.
42. Wakefield JC (1992b). Disorder as harmful dysfunction: a conceptual critique of DSM-III-R's definition of mental disorder. Psychological Review 99, 232-247.
43. Wakefield JC (1993). Limits of operationalization: a critique of Spitzer and Endicott's (1978) proposed operational criteria for mental disorder. Journal of Abnormal Psychology 102, 160-172.
44. Wakefield JC (1996). DSM-IV: are we making diagnostic progress? Contemporary Psychology 41, 646-652.
45. Wakefield JC (1997a). Diagnosing DSM-IV, Part 1: DSM-IV and the concept of mental disorder. Behavior Research and Therapy 35, 633-650.
46. Wakefield JC (1997b). Diagnosing DSM-IV, part 2: Eysenck (1986) and the essentialist fallacy. Behaviour Research and Therapy 35, 651-666.
47. Wakefield JC (1999a). Evolutionary versus prototype analyses of the concept of disorder. Journal of Abnormal Psychology 108, 374-399.
48. Wakefield JC (1999b). Disorder as a black box essentialist concept. Journal of Abnormal Psychology 108, 465-472.
49. Wakefield JC (2006). The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry 6, 149-156.
50. Wakefield JC (2008). The perils of dimensionalization: distinguishing personality traits from personality disorders. Psychiatric Clinics of North America USA 31, 379-393.
51. Wakefield JC (2009). Disability and diagnosis: should role impairment be eliminated from DSM/ICD diagnostic criteria? World Psychiatry 8, 87-88.
52. Wakefield JC (2010a). False positives in psychiatric diagnosis: implications for human freedom. Theoretical Medicine and Bioethics 31, 5-17.
53. Wakefield JC (2010b). Misdiagnosing normality: psychiatry's failure to address the problem of false positive diagnoses of mental disorder in a changing professional environment. Journal of Mental Health 19, 337-351.
54. Wakefield JC (2013a). The DSM-5 debate over the bereavement exclusion: psychiatric diagnosis and the future of empirically supported practice. Clinical Psychology Review 33, 825-845.
55. Wakefield JC (2013b). DSM-5 and clinical social work: mental disorder and psychological justice as goals of clinical intervention. Clinical Social Work Journal 41, 131-138.
56. Wakefield JC (2013c). DSM-5 and the general definition of personality disorder. Clinical Social Work Journal 41, 168-183.
57. Wakefield JC (2014). Wittgenstein's nightmare: why the RDoC grid needs a conceptual dimension. World Psychiatry 13, 38-40.
58. Wakefield JC (2015). Psychological justice: DSM-5, false positive diagnosis, and fair equality of opportunity. Public Affairs Quarterly 29, 33-76.
59. Wakefield JC, First MB (2012). Does the empirical evidence support the proposal to eliminate the major depression "bereavement exclusion" in DSM-5? World Psychiatry 11, 3-10.
60. Wakefield JC, First MB (2013a). Clarifying the boundary between normality and disorder: a fundamental conceptual challenge for psychiatry. Canadian Journal of Psychiatry 58, 603-605.
61. Wakefield JC, First MB (2013b). Diagnostic validity and the definition of mental disorder: a program for conceptually advancing psychiatry. Canadian Journal of Psychiatry 58, 653-655.
62. Wakefield JC, Schmitz MF (2010). The measurement of mental disorder. In A Handbook for the Study of Mental Health: Social Contexts, Theories, and Systems (ed. T Teresa Scheid and T Brown), pp. 20-45. Cambridge University Press: New York.
63. Wakefield JC, Schmitz MF (2011). The challenge of measurement of mental disorder in community surveys. In The Sage Handbook of Mental Health and Illness (ed. D Pilgrim, A Rogers and B Pescosolido), pp. 26-48. Sage: New York.
64. Wakefield JC, Schmitz MF (2012). Recurrence of bereavement-related depression: evidence for the validity of the DSM-IV bereavement exclusion from the Epidemiologic Catchment Area Study. Journal of Nervous and Mental Disease 200, 480-485.
65. Wakefield JC, Schmitz MF (2013a). Can the DSM's major depression bereavement exclusion be validly extended to other stressors?: evidence from the NCS. Acta Psychiatrica Scandinavica 128, 294-305.
66. Wakefield JC, Schmitz MF (2013b). Normal vs. disordered bereavement-related depression: are the differences real or tautological? Acta Psychiatrica Scandinavica 127, 159-168.
67. Wakefield JC, Schmitz MF (2013c). When does depression become a disorder? Using recurrence rates to evaluate the validity of proposed changes in major depression diagnostic thresholds. World Psychiatry 12, 44-52.
68. Wakefield JC, Schmitz MF (2014a). Predictive validation of single-episode uncomplicated depression as a benign subtype of unipolar major depression. Acta Psychiatrica Scandinavica 129, 445-457.
69. Wakefield JC, SchmitzMF (2014b). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry 13, 317-319.
70. Wakefield JC, Schmitz MF (2014c). Uncomplicated depression, suicide attempt, and the DSM-5 bereavement-exclusion debate: an empirical evaluation. Research on Social Work Practice 24, 37-49.
71. Wakefield JC, Schmitz MF (2014d). Corrigendum: how many people have alcohol use disorders?: using the harmful dysfunction analysis to reconcile prevalence estimates in two community surveys. Frontiers in Psychiatry 5, doi: 10.3389/fpsyt.2014.00144, 1-3.
72. Wakefield JC, Schmitz MF (2014e). How many people have alcohol use disorders? using the harmful dysfunction analysis to reconcile prevalence estimates in two community surveys. Frontiers in Psychiatry 5, doi: 10.3389/fpsyt.2014. 00010, 1-22.
73. Wakefield JC, Schmitz MF (2015). The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates. Addiction Published online 26 January 2015, DOI: 10.1111/ add.12859, 1-33.
74. Wakefield JC, Spitzer RL (2002). Lowered estimates-but of what? Archives of General Psychiatry 59, 129-130.
75. Wakefield JC, Schmitz MF, First MB, Horwitz AV (2007). Should the bereavement exclusion for major depression be extended to other losses? Evidence from the National Comorbidity Survey. Archives of General Psychiatry 64, 433-440.
76. Wakefield JC, Schmitz MF, Baer JC (2010). Does the DSMIV clinical significance criterion for major depression reduce false positives? Evidence from the NCS-R. American Journal of Psychiatry 167, 298-304.
77. Wakefield JC, Schmitz MF, Baer JC (2011a). Did narrowing the major depression bereavement exclusion from DSM-III-R to DSM-IV increase validity? Evidence from the NCS. Journal of Nervous and Mental Disease 199, 66-73.
78. Wakefield JC, Schmitz MF, Baer JC (2011b). Relation between duration and severity in bereavement-related depression. Acta Psychiatrica Scandinavica 124, 487-494.
79. Zimmerman M., Chelminski I, Young D (2004). On the threshold of disorder: a study of the impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice. Journal of Clinical Psychiatry 65, 1400-1405.
80. Zimmerman M, Ruggero CJ, Chelminski I, Young D (2008). Is bipolar disorder overdiagnosed? Journal of Clinical Psychiatry 69, 935-940.
81. Zoëga H, Valdimarsdóttir UA, Hernández-Díaz S (2012). Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study. Pediatrics 130, 1012-1018.